Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: Results of the ENECA study

European Journal of Heart Failure

Volumn 7, Issue 4, 2005, Pages 631-639

  Edes, Istvan ^a   Gasior, Zbigniew ^b   Wita, Krystian ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Chronic heart failure; Ejection fraction; Left ventricular function; Nebivolol

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEBIVOLOL; PLACEBO;

AGED; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; KIDNEY FUNCTION TEST; LABORATORY TEST; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; BENZOPYRANS; DOUBLE-BLIND METHOD; ETHANOLAMINES; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; QUALITY OF LIFE; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 19544370840     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.10.015     Document Type: Article

References (33)

1. No authors listed. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. Am J Cardiol 1999;83:1A-38A.
2. E.D. Peterson, L.J. Shaw, and R.M. Califf Risk stratification after myocardial infarction Ann. Intern. Med. 126 1997 561 582
3. B.M. Massie, and N.B. Shah Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management Am. Heart J. 133 1997 703 712
4. P. Lechat, M. Packer, S. Chalon, M. Cucherot, T. Arab, and J.-P. Boissel Clinical effects of β-adrenergic blockade in chronic heart failure. A meta analysis of double-blind, placebo-controlled, randomized trials Circulation 98 1998 1184 1191
5. CIBIS Investigators and Committees A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS) Circulation 90 1994 1765 1771
6. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial Lancet 353 1999 9 13
7. W.S. Colucci, M. Packer, M.R. Bristow, E.M. Gilbert, J.N. Cohn, M.B. Fowler for the US Carvedilol Heart Failure Study Group Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure Circulation 94 1996 2800 2806
8. M.R. Bristow, E.M. Gilbert, W.T. Abraham, K.F. Adams, M.B. Fowler, R.E. Hershberger for the MOCHA Investigators Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure Circulation 94 1996 2807 2816
9. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert for the US Carvedilol Heart Failure Study Group The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N. Engl. J. Med. 334 1996 1349 1355
10. L.H. Opie Beta-blocking agents Drugs for the heart 2001 Saunders Philadelphia 1 32
11. 125I]iodocyanopindolol binding studies Eur. J. Pharmacol. 460 2003 19 26
12. M. Dawes, S.E. Brett, P.J. Chowienczyk, T.G.K. Mant, and J.M. Ritter The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension Br. J. Clin. Pharmacol. 48 1999 460 463
13. N. Tzemos, P.O. Lim, and T.M. MacDonald Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized double blind, crossover study Circulation 104 2001 511 514
14. M.A.W. Broeders, P.A. Doevendans, B. Bekkers, R. Bronsaer, E. vanGorsel, and J.W.M. Heemskerk Nebivolol: a third-generation β-blocker that augments vascular nitric oxide release Circulation 102 2000 677 684
15. N. Sharpe Benefit of β-blockers for heart failure proven in 1999 Lancet 353 1999 1988 1989
16. Cockcroff Nebivolol vasodilates human foramen musculature: evidence for an l-arginine NO-dependent mechanism J. Pharmacol. Exp. Ther. 274 1995 1067 1071
17. G. Hasenfuss, C. Holubarsch, H.P. Hermann, K. Astheimer, and B.J.H. Pieske Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing heart and in patients with dilated cardiomyopathy Eur. Heart J. 15 1994 164 170
18. B. Pieske, G. Hasenfuss, C. Holubarsch, R. Schwinger, M. Bohm, and H. Just Alterations of the force-frequency relationship in the failing human heart depend on the underlying cardiac disease Basic Res. Cardiol. 87 Suppl. 1 1992 213 221
19. B. Pieske, B. Kretschmann, M. Meyer, C. Holubarsch, J. Weirich, and H. Posival Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy Circulation 92 1995 1169 1178
20. M.G. Marinone, F. Al-Nassar, D. Francis, and M.F. Piepoli Beta-blocking in heart failure patients. Balancing the evidence Int. J. Cardiol. 79 2001 5 12
21. S.L. Woodley, E.M. Gilbert, J.L. Anderson, J.B. O'Connell, D. Deitchman, and F.G. Yanowitz Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy Circulation 84 1991 2426 2441
22. M. Packer, G.V. Antonopoulos, J.A. Berlin, J. Chittams, M.A. Konstam, and J.E. Udelson Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis Am. Heart J. 141 2001 899 907
23. M.T. Kearney, K.A. Fox, A.J. Lee, R.J. Prescott, A.M. Shah, and P.D. Batin Predicting death due to progressive heart failure in patients with mild-to moderate chronic heart failure J. Am. Coll. Cardiol. 40 2002 1801 1808
24. G. Cintron, G. Johnson, G. Francis, F. Cobb, and J.N. Cohn Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure: the V-HeFT VA Cooperative Studies Group Circulation 87 1993 17 23 (Suppl.)
25. L. Stoleru, W. Wijns, C. van Eyll, T. Bouvy, L. Van Nueten, and H. Pouleur Effects of d-nebivolol and l-nebivolol on left ventricular systolic and diastolic function: comparison with d-l-nebivolol and atenolol J. Cardiovasc. Pharmacol. 22 1993 183 190
26. M. Goldstein, J.L. Vincent, J.M. De Smet, L. Barvais, L. Van Nueten, and H. Scheijgrond Administration of nebivolol after coronary artery bypass in patients with altered left ventricular function J. Cardiovasc. Pharmacol. 22 1993 253 258
27. T. Wisenbaugh, I. Katz, J. Davis, R. Essop, J. Skoularigis, and S. Middlemost Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy J. Am. Coll. Cardiol. 21 1993 1094 1100
28. O. Uhlir, I. Dvorak, P. Gregor, I. Malek, L. Spinarova, and J. Vojacek Nebivolol in the treatment of cardiac failure: a double-blind controlled clinical trial J. Card. Fail. 3 1997 271 276
29. M.F. Rousseau, F. Chapelle, and C. Van Eyll Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction J. Card. Fail. 2 1996 15 23
30. S. Nodari, M. Metra, and L. Dei Cas Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol Eur. J. Heart Fail. 5 2003 621 627
31. O. Kamp, G.T. Sieswerda, and C.A. Visser Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension Am. J. Cardiol. 92 2003 344 348
32. B. Brehm, S.C. Wolf, S. Gorner, N. Buck-Muller, and T. Risler Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study Eur. J. Heart Fail. 4 2002 757 763
33. M.C. Shibata, M.D. Flather, M. Bohm, J. Borbola, A. Cohen-Solal, and L. Dumitrascu Study of the effects of nebivolol intervention on outcomes and rehospitalisation in seniors with heart failure (SENIORS). Rationale and design Int. J. Cardiol. 86 2002 77 85